EP2103607A4 - Dérivé de 1-phényl 1-thio-d-glucitol - Google Patents

Dérivé de 1-phényl 1-thio-d-glucitol

Info

Publication number
EP2103607A4
EP2103607A4 EP07850604A EP07850604A EP2103607A4 EP 2103607 A4 EP2103607 A4 EP 2103607A4 EP 07850604 A EP07850604 A EP 07850604A EP 07850604 A EP07850604 A EP 07850604A EP 2103607 A4 EP2103607 A4 EP 2103607A4
Authority
EP
European Patent Office
Prior art keywords
thio
phenyl
glucitol derivative
glucitol
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07850604A
Other languages
German (de)
English (en)
Other versions
EP2103607A1 (fr
Inventor
Hiroyuki Kakinuma
Takahiro Oi
Yuko Hashimoto
Hitomi Takahashi
Yohei Kobayashi
Yuki Iwata
Kenichi Kawabe
Masato Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of EP2103607A1 publication Critical patent/EP2103607A1/fr
Publication of EP2103607A4 publication Critical patent/EP2103607A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/02—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
EP07850604A 2006-12-14 2007-12-14 Dérivé de 1-phényl 1-thio-d-glucitol Withdrawn EP2103607A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006336517 2006-12-14
PCT/JP2007/074100 WO2008072726A1 (fr) 2006-12-14 2007-12-14 Dérivé de 1-phényl 1-thio-d-glucitol

Publications (2)

Publication Number Publication Date
EP2103607A1 EP2103607A1 (fr) 2009-09-23
EP2103607A4 true EP2103607A4 (fr) 2011-01-05

Family

ID=39511739

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07850604A Withdrawn EP2103607A4 (fr) 2006-12-14 2007-12-14 Dérivé de 1-phényl 1-thio-d-glucitol

Country Status (8)

Country Link
US (1) US20100069460A1 (fr)
EP (1) EP2103607A4 (fr)
JP (1) JPWO2008072726A1 (fr)
CN (1) CN101611023A (fr)
AU (1) AU2007332476A1 (fr)
CA (1) CA2672176A1 (fr)
RU (1) RU2009126767A (fr)
WO (1) WO2008072726A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1527338B1 (fr) 2002-07-26 2011-08-31 Instrumentation Laboratory Company Procede de reduction du taux de perte d'oxygene de solutions aqueuses
TW200637839A (en) * 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives
WO2010009243A1 (fr) 2008-07-15 2010-01-21 Theracos, Inc. Dérivés de benzylbenzène deutérés et procédés d’utilisation
JP2010180143A (ja) * 2009-02-03 2010-08-19 Taisho Pharmaceutical Co Ltd ４−（置換ベンジル）−２−ハロフェノール誘導体の製造法
AR076317A1 (es) * 2009-04-16 2011-06-01 Taisho Pharmaceutical Co Ltd Composiciones farmaceuticas que comprenden un compuesto de 1-tio-d-glucitol.
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2582709B1 (fr) 2010-06-18 2018-01-24 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012025857A1 (fr) 2010-08-23 2012-03-01 Hetero Research Foundation Dérivés de cycloalkyl méthoxybenzyl phényl pyrane en tant qu'inhibiteurs du cotransporteur de glucose sodium-dépendant (sglt2)
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2760862B1 (fr) 2011-09-27 2015-10-21 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
CN104955481B (zh) 2013-02-04 2017-10-24 大正制药株式会社 便秘症的预防或治疗药
AU2014317663B2 (en) * 2013-09-09 2018-02-08 Youngene Therapeutics Co., Ltd. C-aryl glucoside derivative, preparation method for same, and medical applications thereof
EP3762379A1 (fr) 2018-03-07 2021-01-13 Bayer Aktiengesellschaft Identification et utilisation d'inhibiteurs d'erk5
US12240855B2 (en) 2019-03-06 2025-03-04 Daiichi Sankyo Company, Limited Pyrrolopyrazole derivative
EP4177245A1 (fr) * 2020-07-10 2023-05-10 Adama Agan Ltd. Procédé et intermédiaires pour la préparation de fenoxasulfone

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE216704T1 (de) 1996-12-26 2002-05-15 Tanabe Seiyaku Co Propiophenonderivate und verfahren zu ihrer herstellung
ES2254376T3 (es) 2000-03-17 2006-06-16 Kissei Pharmaceutical Co., Ltd. Derivados glucopiranosiloxibencilbenceno, preparaciones medicinales que los contienen e intermediarios para la preparacion de los indicados derivados.
TWI243162B (en) 2000-11-10 2005-11-11 Taisho Pharmaceutical Co Ltd Cyanopyrrolidine derivatives
CA2448741C (fr) 2001-05-30 2010-06-22 Kissei Pharmaceutical Co., Ltd. Derive de glucopyranosyloxypyrazole, composition medicinale contenant celui-ci, et utilisation medicinale et intermediaire de celui-ci
BRPI0313290B1 (pt) 2002-08-08 2016-12-06 Kissei Pharmaceutical derivados de pirazol, promedicamento, composição farmacêutica, agentes terapêuticos e uso medicinal
MXPA05000725A (es) 2002-08-09 2005-04-08 Taisho Pharma Co Ltd Procedimiento para la produccion selectiva de aril-5-tio-??-d-aldohexopiranosidos.
JP2004137245A (ja) 2002-08-23 2004-05-13 Kissei Pharmaceut Co Ltd ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
WO2004019958A1 (fr) 2002-08-27 2004-03-11 Kissei Pharmaceutical Co., Ltd. Derives de pyrazole, composition medicinale contenant ces derives et utilisation medicinale de celle-ci
EP1568380A4 (fr) 2002-12-04 2009-10-21 Kissei Pharmaceutical Prevention ou traitement de maladies dues a l'hyperglycemie
WO2004089966A1 (fr) 2003-04-01 2004-10-21 Taisho Pharmaceutical Co., Ltd. Procede de preparation selective de 5-thio-$g(b)-d-aldohexopyranoside heteroaryle
JPWO2004106352A1 (ja) 2003-05-29 2006-07-20 大正製薬株式会社 アルドヘキソピラノース中間体の製造法
DE102004028241B4 (de) 2004-06-11 2007-09-13 Sanofi-Aventis Deutschland Gmbh Neue Fluorglykosidderivate von Pyrazolen, diese Verbindungen enthaltende Arzneimittel und Herstellung dieser Arzneimittel
JP2008514546A (ja) 2004-09-30 2008-05-08 大正製薬株式会社 ピリジン誘導体及びその使用に関連する治療法
WO2006051662A1 (fr) 2004-11-09 2006-05-18 Taisho Pharmaceutical Co., Ltd. Derive de thiazole
WO2006054629A1 (fr) * 2004-11-18 2006-05-26 Kissei Pharmaceutical Co., Ltd. COMPOSÉS HÉTÉROCYCLIQUES AZOTÉS SUBSTITUÉS EN POSITION 1 ET AYANT UN GROUPE β-D-GLUCOPYRANOSYLE EN POSITION 3 ET MÉDICAMENTS CONTENANT CEUX-CI
TW200637839A (en) 2005-01-07 2006-11-01 Taisho Pharmaceutical Co Ltd 1-thio-d-glucitol derivatives

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
CN101611023A (zh) 2009-12-23
EP2103607A1 (fr) 2009-09-23
RU2009126767A (ru) 2011-01-20
CA2672176A1 (fr) 2008-06-19
AU2007332476A1 (en) 2008-06-19
JPWO2008072726A1 (ja) 2010-04-02
US20100069460A1 (en) 2010-03-18
WO2008072726A1 (fr) 2008-06-19

Similar Documents

Publication Publication Date Title
CR10841A (es) Imidazotriazinas imidazopirimidinas inhibidores de cinasa
ATE475662T1 (de) Dihydropyrazolopyrimidinonderivate
ATE483711T1 (de) Spiroindolinonderivate
ATE469905T1 (de) Pyridopyrimidinonderivate
ATE512135T1 (de) Spiroindolinonderivate
DE602007008423D1 (de) Flüssigkeitshärtung
DE602007009267D1 (de) Reifenaufblasverfahren
EP2072519A4 (fr) Dérivé de diarylcétimine
DK2035394T3 (da) 2-pyrazincarboxamidderivater
ATE524477T1 (de) Aziridinylepothilonverbindungen
ATE546437T1 (de) Aminomethyl-4-imidazole
DE502007000218D1 (de) nsetzungen
DK2086968T3 (da) 5-hydroxymethyl-oxazolidin-2-on-derivater
DE112007003147A5 (de) Rohr-Biegevorrichtung
FI20061014A0 (fi) Diffuusiopinnoitusmenetelmä
DE602007012951D1 (de) Verbundschraubenausräumtür
DE502007005975D1 (de) Wischblatt
FI20060691A0 (fi) Laitekotelointi
FR2902426B1 (fr) Derives de cinnamoyl-piperazine
DE112007001125A5 (de) Käfigmutter
ATE473994T1 (de) Avermectinderivate
CR10205A (es) Compuestos de cinamida policiclicos
UA13797S (uk) Сірник
FI20070158A0 (fi) Järjestely
FI7355U1 (fi) Esiintymislava

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090609

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: TAKAHASHI, MASATO

Inventor name: KAWABE, KENICHI

Inventor name: IWATA, YUKI

Inventor name: KOBAYASHI, YOHEI

Inventor name: TAKAHASHI, HITOMI

Inventor name: HASHIMOTO, YUKO

Inventor name: OI, TAKAHIRO

Inventor name: KAKINUMA, HIROYUKI

A4 Supplementary search report drawn up and despatched

Effective date: 20101202

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 43/00 20060101ALI20110329BHEP

Ipc: A61P 31/04 20060101ALI20110329BHEP

Ipc: A61P 27/02 20060101ALI20110329BHEP

Ipc: A61P 25/00 20060101ALI20110329BHEP

Ipc: A61P 19/06 20060101ALI20110329BHEP

Ipc: A61P 13/12 20060101ALI20110329BHEP

Ipc: A61P 9/12 20060101ALI20110329BHEP

Ipc: A61P 9/10 20060101ALI20110329BHEP

Ipc: A61P 9/04 20060101ALI20110329BHEP

Ipc: A61P 7/10 20060101ALI20110329BHEP

Ipc: A61P 3/10 20060101ALI20110329BHEP

Ipc: A61P 3/08 20060101ALI20110329BHEP

Ipc: A61P 3/06 20060101ALI20110329BHEP

Ipc: A61P 3/04 20060101ALI20110329BHEP

Ipc: A61K 31/382 20060101ALI20110329BHEP

Ipc: C07D 335/02 20060101AFI20110329BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110830